xylocaine 2% with adrenaline 1:200,000
pharmacy retailing (nz) ltd t/a healthcare logistics - adrenaline acid tartrate 0.0091 mg/ml; ; lidocaine hydrochloride 20 mg/ml; adrenaline acid tartrate 0.0091 mg/ml; lidocaine hydrochloride 20 mg/ml - solution for injection - active: adrenaline acid tartrate 0.0091 mg/ml lidocaine hydrochloride 20 mg/ml excipient: hydrochloric acid sodium chloride sodium metabisulfite water for injection active: adrenaline acid tartrate 0.0091 mg/ml lidocaine hydrochloride 20 mg/ml excipient: hydrochloric acid sodium chloride sodium hydroxide sodium metabisulfite water for injection - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques: · local infiltration · minor or major nerve blocks · epidural block · arthroscopy · intravenous regional anaesthesia
pontevia 120 mg solution for injection in pre-filled syringe
zuellig pharma sdn bhd - galcanezumab -
pontevia 120 mg solution for injection in pre-filled pen
zuellig pharma sdn bhd - galcanezumab -
herzuma 150mg powder for concentrate for solution for infusion vials
napp pharmaceuticals ltd - trastuzumab - powder for solution for infusion - 150mg
simulect 20mg powder and solvent for solution for injection vials
novartis pharmaceuticals uk ltd - basiliximab - powder and solvent for solution for injection - 20mg
timoptic in ocudose- timolol maleate solution
amring pharmaceuticals inc. - timolol maleate (unii: p8y54f701r) (timolol anhydrous - unii:5jky92s7br) - preservative-free timolol maleate ophthalmic solution usp in the unit dose vial is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. preservative-free timolol maleate ophthalmic solution usp in the unit dose vial may be used when a patient is sensitive to the preservative in timolol maleate ophthalmic solution usp, benzalkonium chloride, or when use of a preservative-free topical medication is advisable. preservative-free timolol maleate ophthalmic solution usp in the unit dose vial is contraindicated in patients with (1) bronchial asthma; (2) a history of bronchial asthma; (3) severe chronic obstructive pulmonary disease (see warnings); (4) sinus bradycardia; (5) second or third degree atrioventricular block; (6) overt cardiac failure (see warnings); (7) cardiogenic shock; or (8) hypersensitivity to any component of this product.
simulect 10mg powder and solvent for solution for injection vials
novartis pharmaceuticals uk ltd - basiliximab - powder and solvent for solution for injection - 10mg
mycophenolate mofetil tablet, film coated
aphena pharma solutions - tennessee, llc - mycophenolate mofetil (unii: 9242ecw6r0) (mycophenolic acid - unii:hu9dx48n0t) - mycophenolate mofetil 500 mg - mycophenolate mofetil is indicated for the prophylaxis of organ rejection in patients receiving allogeneic renal, cardiac or hepatic transplants. mycophenolate mofetil should be used concomitantly with cyclosporine and corticosteroids. allergic reactions to mycophenolate mofetil have been observed; therefore, mycophenolate mofetil is contraindicated in patients with a hypersensitivity to mycophenolate mofetil, mycophenolic acid or any component of the drug product.
tacrograf tacrolimus 5 mg capsule bottle
arrotex pharmaceuticals pty ltd - tacrolimus monohydrate, quantity: 5.112 mg (equivalent: tacrolimus, qty 5 mg) - capsule, hard - excipient ingredients: hypromellose; lactose monohydrate; croscarmellose sodium; magnesium stearate; gelatin; purified water; sodium lauryl sulfate; brilliant blue fcf; phloxine b; titanium dioxide; quinoline yellow; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide; ethanol absolute - adjunct to liver, kidney, lung or heart allograft transplantation in adults and children.
tacrograf tacrolimus 1 mg capsule bottle
arrotex pharmaceuticals pty ltd - tacrolimus monohydrate, quantity: 1.022 mg (equivalent: tacrolimus, qty 1 mg) - capsule, hard - excipient ingredients: hypromellose; lactose monohydrate; croscarmellose sodium; magnesium stearate; gelatin; purified water; sodium lauryl sulfate; brilliant blue fcf; iron oxide yellow; titanium dioxide; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide; ethanol absolute - adjunct to liver, kidney, lung or heart allograft transplantation in adults and children.